Gonadorelin (2 mg Vial) Dosage Protocol

Quickstart Highlights

Gonadorelin dosage supports the restoration of natural LH and FSH release from the pituitary gland, reactivating the hypothalamic‑pituitary‑gonadal (HPG) axis^[1]. As a synthetic form of gonadotropin‑releasing hormone (GnRH), gonadorelin stimulates testosterone production in men and promotes ovulation in women when administered in short, pulsatile doses^[2]^[3]. This educational protocol outlines a subcutaneous micro‑dosing approach using a practical dilution for accurate insulin‑syringe measurements.

Reconstitute: Add 2.0 mL bacteriostatic water → 1 mg/mL concentration (1000 mcg/mL).

Typical dose range: 50–250 mcg per injection, 2–3 times weekly.

Easy measuring: At 1 mg/mL, 1 unit = 0.01 mL = 10 mcg on a U‑100 insulin syringe.

Storage: Lyophilized: store at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); avoid freeze–thaw cycles.

Dosing & Reconstitution Guide

Educational guide for reconstitution and periodic dosing

Standard / Maintenance Approach (2 mL = 1 mg/mL)

Route: Subcutaneous injection. Frequency: 2–3 times per week on non‑consecutive days (e.g., Mon/Wed/Fri or Tue/Thu/Sat).

Week/Phase	Dose per Injection (mcg)	Units (mL)
Weeks 1–2 (Initiation)	50 mcg	5 units (0.05 mL)
Weeks 3–4 (Titration)	100 mcg	10 units (0.10 mL)
Weeks 5–8 (Maintenance)	100–150 mcg	10–15 units (0.10–0.15 mL)

For ≤10‑unit (≤0.10 mL) administrations, consider 30‑ or 50‑unit insulin syringes for improved readability.

Reconstitution Steps

Draw 2.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label concentration (1 mg/mL) and date; refrigerate at 2–8 °C (35.6–46.4 °F), protected from light.

Advanced / Post‑Cycle Support Approach

Route: Subcutaneous injection. Frequency: Daily or every other day for short cycles (limit to ≤14 consecutive days to avoid pituitary desensitization).

Week/Phase	Dose per Injection (mcg)	Units (mL)
Days 1–7 (Burst)	200 mcg	20 units (0.20 mL)
Days 8–14 (Taper)	100 mcg	10 units (0.10 mL)
Week 3+ (Optional Maintenance)	100 mcg 2–3×/wk	10 units (0.10 mL)

Important: Limit consecutive daily dosing to ≤14 days. Extended continuous administration may lead to GnRH receptor desensitization and reduced LH/FSH response^[4].

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on a 4–8 week protocol with 2–3 injections per week.

Peptide Vials (Gonadorelin, 2 mg each):

4 weeks (100 mcg × 3/wk) ≈ 1 vial
6 weeks (100 mcg × 3/wk) ≈ 1 vial
8 weeks (150 mcg × 3/wk) ≈ 2 vials

Insulin Syringes (U‑100, 30‑ or 50‑unit preferred):

Per week: 3 syringes
4 weeks: 12 syringes
6 weeks: 18 syringes
8 weeks: 24 syringes

Bacteriostatic Water (10 mL bottles): Use 2.0 mL per vial for reconstitution.

4–6 weeks (1 vial): 2 mL → 1 × 10 mL bottle
8 weeks (2 vials): 4 mL → 1 × 10 mL bottle

Alcohol Swabs: One for the vial stopper + one for the injection site each administration.

Per week: 6 swabs (2/injection × 3 injections)
4 weeks: 24 swabs
6 weeks: 36 swabs
8 weeks: 48 swabs → recommend 1 × 100‑count box

View Supplier

Protocol Overview

Concise summary of the periodic micro‑dosing regimen.

Goal: Stimulate endogenous LH and FSH release to support testosterone production and testicular function^[1]^[5].

Schedule: Subcutaneous injections 2–3 times weekly for 4–8 weeks; limit daily dosing to ≤14 consecutive days.

Dose Range: 50–200 mcg per injection based on goals and response.

Reconstitution: 2.0 mL per 2 mg vial (1 mg/mL) for accurate unit measurements.

Storage: Lyophilized frozen; reconstituted refrigerated; avoid repeated freeze–thaw.